Prakt. lékáren. 2016; 12(6): 227-230 | DOI: 10.36290/lek.2016.055

Nasal corticosteroids in a treatment of rhinosinusitis

Jan Rottenberg
Klinika ORL a chirurgie hlavy a krku FN u sv. Anny v Brně

Nasal corticosteroids represent the baseline therapy especially in case of chronic rhinosinusitis namely in allergic rhinosinusitis and

rhinosinusitis related to nasal polyposis. The active substances available on the market do not vary in terms of efficacy but may

considerably vary in terms of side effects. The most common side effects are those related to local nasal mucosa impairment. The

adverse reactions related to the level of topical steroids’ bioavailability are rather rare. The publication summarizes basic information

about indications, contraindications, adverse effects as well as some practical aspects of treatment by topical nasal steroids.

Keywords: topical nasal corticosteroids, rhinosinusitis, adverse reactions, indications

Published: December 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Rottenberg J. Nasal corticosteroids in a treatment of rhinosinusitis. Praktické lékárenství. 2016;12(6):227-230. doi: 10.36290/lek.2016.055.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bergmann J, Witmer MT, Slonim CB. The relationship of intranasal steroids to intraocular pressure. Curr Allergy Asthma Rep. 2009; 9(4): 311-315. Go to original source... Go to PubMed...
    2. Fowler PD, Gazis AG, Page SR, Jones NS. A randomized double-blind study to compare the effects of nasal fluticasone and betamethasone on the hypothalamo-pituitary-adrenal axis and bone turnover in patients with nasal polyposis. Clin Otolaryngol Allied Sci. 2002; 27(6): 489-493. Go to original source... Go to PubMed...
    3. Mygind N, Lund V. Intranasal corticosteroids for nasal polyposis : biological rationale, efficacy, and safety. Treat Respir Med. 2006; 5(2): 93-102. Go to original source...
    4. Intranasal Corticosteroids a Supplement to the OTC Products Chart, January, 2004, RxFiles Academy Detailing Program, www.rxfiles.ca, dostupné z: http://www.rxfiles.ca/rxfiles/uploads/documents/otc-topical-nasal-steroids.pdf
    5. Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics. 2000; 105(2): E22. Go to original source... Go to PubMed...
    6. Skoner DP, et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics 2000; 105: E23. Go to original source... Go to PubMed...
    7. Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database Syst Rev. 2011; (8): CD009274. doi: 10.1002/14651858.CD009274. Go to original source...
    8. Waddell AN, Patel SK, Toma AG, Maw AR. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? Laryngol Otol. 2003; 117(11): 843-845. Go to original source... Go to PubMed...
    9. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998; 317(7173): 1624-1629. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.